140 related articles for article (PubMed ID: 2569938)
1. CD8 suppressor cell activity and its effect on CD4 helper cell-dependent growth of SJL/J B-cell lymphomas.
Thrush GR; Butch AW; Lerman SP
Cell Immunol; 1989 Sep; 122(2):555-62. PubMed ID: 2569938
[TBL] [Abstract][Full Text] [Related]
2. The CD4 cell dependency of SJL/J B-cell lymphomas as a target for cyclophosphamide therapy.
Thrush GR; Placey JL; Valeriote FA; Lerman SP
Cancer Commun; 1989; 1(5):301-10. PubMed ID: 2518399
[TBL] [Abstract][Full Text] [Related]
3. T-helper-cell-specific monoclonal antibody inhibits growth of B-cell lymphomas in syngeneic SJL/J mice.
Alisauskas RM; Ponzio NM
Cell Immunol; 1989 Apr; 119(2):286-303. PubMed ID: 2467748
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide treatment of an SJL murine B-cell lymphoma increases the proportion of suppressive CD8+ over tumor-stimulatory CD4+ T-lymphocytes.
Wrone-Smith T; Cankovic M; VanBuren E; Lerman S
Leuk Res; 1993 Nov; 17(11):967-75. PubMed ID: 8231237
[TBL] [Abstract][Full Text] [Related]
5. Human epidermal cells from ultraviolet light-exposed skin preferentially activate autoreactive CD4+2H4+ suppressor-inducer lymphocytes and CD8+ suppressor/cytotoxic lymphocytes.
Baadsgaard O; Fox DA; Cooper KD
J Immunol; 1988 Mar; 140(6):1738-44. PubMed ID: 2964481
[TBL] [Abstract][Full Text] [Related]
6. Influence of T-helper cell specific monoclonal antibody on progressive growth of B-cell lymphomas in SJL/J mice: correlation of acute treatment dosage with tumor dormancy or complete remission in long-term survivors.
Alisauskas RM; Friedman CA; Ponzio NM
Cancer Commun; 1990; 2(1):33-43. PubMed ID: 2142432
[TBL] [Abstract][Full Text] [Related]
7. Growth of SJL/J-derived transplantable reticulum cell sarcoma as related to its ability to induce T-cell proliferation in the host. I. Dominant negative genetic influences of other parent haplotype in F1 hybrids of SJL/J mice.
Katz IR; Lerman SP; Ponzio NM; Shreffler DC; Thorbecke GJ
J Exp Med; 1980 Feb; 151(2):347-61. PubMed ID: 6985949
[TBL] [Abstract][Full Text] [Related]
8. The SJL/J T cell response to both spontaneous and transplantable syngeneic reticulum cell sarcoma is mediated predominantly by the V beta 17a+ T cell clonotype.
Katz JD; Ohnishi K; Lebow LT; Bonavida B
J Exp Med; 1988 Nov; 168(5):1553-62. PubMed ID: 2460577
[TBL] [Abstract][Full Text] [Related]
9. Alloantigen-specific T suppressor-inducer and T suppressor-effector cells can be activated despite blocking the IL-2 receptor.
Tan P; Anasetti C; Martin PJ; Hansen JA
J Immunol; 1990 Jul; 145(2):485-8. PubMed ID: 1973183
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Ia+ reticulum cell sarcoma (RCS) growth in syngeneic SJL/J mice. I. Inhibition of tumor growth by passive administration of L3T4 monoclonal antibody before or after tumor inoculation.
Ohnishi K; Bonavida B
J Immunol; 1987 Jun; 138(12):4524-9. PubMed ID: 2953807
[TBL] [Abstract][Full Text] [Related]
11. CD8+ suppressor T cell clone capable of inhibiting the antigen- and anti-T cell receptor-induced proliferation of Th clones without cytolytic activity.
Hisatsune T; Enomoto A; Nishijima K; Minai Y; Asano Y; Tada T; Kaminogawa S
J Immunol; 1990 Oct; 145(8):2421-6. PubMed ID: 1976694
[TBL] [Abstract][Full Text] [Related]
12. Characterization of tumor-infiltrating CD4+ T cells as Th1 cells based on lymphokine secretion and functional properties.
Nagarkatti M; Clary SR; Nagarkatti PS
J Immunol; 1990 Jun; 144(12):4898-905. PubMed ID: 1972170
[TBL] [Abstract][Full Text] [Related]
13. Regulation of B-cell lymphoma growth in syngeneic SJL/J mice. establishment of tumor dormancy following administration of anti-CD4 monoclonal antibody into tumor-bearing mice.
Ohnishi K; Bonavida B
Leukemia; 1993 Nov; 7(11):1801-6. PubMed ID: 8231249
[TBL] [Abstract][Full Text] [Related]
14. Role of IL-2, IL-4 and IL-6 in the growth and differentiation of tumor-specific CD4+ T helper and CD8+ T cytotoxic cells.
Selvan RS; Nagarkatti PS; Nagarkatti M
Int J Cancer; 1990 Jun; 45(6):1096-104. PubMed ID: 1972141
[TBL] [Abstract][Full Text] [Related]
15. Distinct subsets of accessory cells activate Thy-1+ triple negative (CD3-, CD4-, CD8-) cells and Th-1 delayed-type hypersensitivity effector T cells.
Matsushima GK; Stohlman SA
J Immunol; 1991 May; 146(10):3322-31. PubMed ID: 1673982
[TBL] [Abstract][Full Text] [Related]
16. Helper and suppressor functions of panned populations of immune peritoneal T cells with reactivity to the rat mammary adenocarcinoma 13762A.
Christensen ND; Kreider JW
Cell Immunol; 1988 Mar; 112(1):200-13. PubMed ID: 2449978
[TBL] [Abstract][Full Text] [Related]
17. CD8+ suppressor cells inhibit staphylococcal protein A-induced gamma interferon production by CD4+ lymphocytes.
Kasparian SS; Menezes J
Immunol Lett; 1991 Jan; 27(1):31-7. PubMed ID: 1673445
[TBL] [Abstract][Full Text] [Related]
18. LPS-stimulated SJL macrophages produce IL-12 and IL-18 that inhibit IgE production in vitro by induction of IFN-gamma production from CD3intIL-2R beta+ T cells.
Yoshimoto T; Nagai N; Ohkusu K; Ueda H; Okamura H; Nakanishi K
J Immunol; 1998 Aug; 161(3):1483-92. PubMed ID: 9686615
[TBL] [Abstract][Full Text] [Related]
19. Regulatory circuits in autoimmunity: recruitment of counter-regulatory CD8+ T cells by encephalitogenic CD4+ T line cells.
Sun D; Ben-Nun A; Wekerle H
Eur J Immunol; 1988 Dec; 18(12):1993-9. PubMed ID: 2905995
[TBL] [Abstract][Full Text] [Related]
20. LD1: a CD4-CD8- TCR alpha beta/CD3+ peripheral T cell line with helper function for B lymphocytes.
Pelkonen J; Palacios R
Int Immunol; 1990; 2(6):555-62. PubMed ID: 2150761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
